The global contract research organization (CRO) services market is undergoing rapid changes with a surge in clinical trials to develop Covid-19 vaccines and treatments.Major CROs are clinching merge and acquisition (M&As) deals, and remote clinical trials are expanding.Following the global trend, th
Bayer's Vitrakvi (ingredient name: larotrectinib) is leading a paradigm shift in cancer treatment designs tailored to treat tumors based on biomarkers rather than specific carcinomas, the company said Tuesday.Patients with NTRK (neurotrophic receptor tyrosine kinase) gene fusion can use Vitrakvi fro
The government has completed negotiations with 58 pharmaceutical companies to retrieve health insurance paid for choline alfoscerate, adjuvant treatment for dementia.Some companies accepted the National Health Insurance Service’s proposal to recollect 20 percent of health insurance covered for the d
Huons Biopharma said Tuesday that it has received approval to conduct a phase 3 clinical trial for its botulinum toxin Liztox, branded a Hutox in the global market, in treating upper limb spasticity after stroke.The company completed the phase 1 trial in November and submitted the plan to enter the
Celltrion said it presented the global phase 3 trial results of its antibody Covid-19 treatment, Regkirona, at a session of the European Congress of Clinical Microbiology & Infectious Disease (ECCMID) on Monday.Dr. Oana Sandulescu from Carol Davila University of Medicine and Pharmacy in Romania made
Genexine will conduct joint research with Phi Biomed and Pohang University of Science and Technology (POSTEC) to develop the next-generation mRNA vaccine that overcomes the limitations of existing mRNA vaccines.The three partners signed an agreement at Genexine headquarters in Seongnam, Gyeonggi Pro
Ferring Korea said Monday that it presented phase 3 clinical trial results of its fertility treatment, Rekovelle (follitropin delta), in Asian women at the European Society of Human Reproduction and Embryology (ESHRE) on June 28.The GRAPE study compared conventional dosing of follitropin alfa with i
Takeda Korea said Monday that it has confirmed the efficacy and safety profile of Kynteles (ingredient: vedolizumab) in Asian adults with moderate to severely active ulcerative colitis.The VARSITY study showed that Kynteles has superior efficacy and safety profile compared to adalimumab, meeting the
MSD’s Keytruda (ingredient: pembrolizumab), immunotherapy for lung cancer, is the company’s flagship item that sold $14.38 billion worldwide last year.However, MSD Korea is struggling with limited reimbursement for Keytruda in Korea.Keytruda was the first immunotherapy to obtain the regulatory nod a
LegoChem Biosciences said that it has signed a collaboration and option license agreement with Cellectar Biosciences, a U.S.-based biopharmaceutical company, in developing a PDC (phospholipid drug conjugates)-based anticancer treatment.Under the accord, the two companies will discover PDC candidates
Novartis said Friday that it would continue to discuss with the domestic regulators to receive reimbursement for its gene therapy Zolgensma, which has effectively reserved motor developments in infants diagnosed with spinal muscular atrophy (SMA).The company hosted an online conference on Friday and
The U.S. FDA revised the label of Biogen’s Aduhelm (ingredient: aducanumab), reducing the number of people eligible for the treatment.On Thursday, the regulator added the information in the label that Aduhelm should be used for “patients with mild cognitive impairment or mild dementia stage of the d
Vivozon Healthcare said Thursday that it has received approval from the Institutional Review Boards (IRBs) of Korea’s four major hospitals to conduct phase 3 clinical trials of its non-opioid analgesic injection, Opiranserin (VVZ-149).The company will conduct the phase 3 study in Seoul National Univ
Local researchers said they have found existing drugs that can be repurposed as an oral treatment for Covid-19.On Thursday, a joint research team of the Korea Advanced Institute of Science and Technology (KAIST)’s Chemical and Biomolecular Engineering Department Professor Lee Sang-yup and Institut P
Celebrating its 10th anniversary, Takeda Korea plans to realize patient-centered and innovative treatment for the next decade, the company's top manager said."Since 2014, Takeda has been pursuing to become a global leader in the specialty field, focusing on four key areas – cancer and rare diseases,
LegoChem Biosciences said Wednesday that it would issue new shares to raise about 160 billion won ($14 million) to speed up global clinical trials of its antibody-drug conjugate (ADC) candidates and add up new pipelines.The company plans to issue 3,013,180 preferred shares at 53,100 won, increasing
The Ministry of Food and Drug Safety has ordered a temporary suspension of making and selling six ethical drugs (ETC) by Samsung Pharmaceutical after confirming various violations in making the drugs.The six drugs include five Samsung Pharmaceutical’s drugs – Geramin, Moarex, Combicin, and Combicin
Korea’s leading pharmaceutical companies are quickly entering the Covid-19 diagnostic kit distribution business.Their move came as the fourth wave of the virus outbreak recently hit the nation despite the increasing rollouts of vaccines.The need for screening asymptomatic Covid-19 cases has also ris
Helixmith said that it has retrieved all CAR-T technology and related rights related to VM801, a chimeric antigen receptor-T (CAR-T) therapy targeting TAG-72 antigen, from Bluebird Bio, a U.S biopharmaceutical company.The company transferred the technology for VM801 to Bluebird Bio in 2015 and grant
Genexine said Wednesday that Indonesia's National Agency of Drug and Food Control has approved the phase 2/3 clinical trial of the Covid-19 vaccine, GX-19N, making it the first Korean company to conduct a global phase 2/3 study.The company will conduct phase 3 clinical trials in 10,000 healthy adult